Sun L - Search Results

1

Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance.

Gulen MF, Bulek K, Xiao H, Yu M, Gao J, Sun L, Beurel E, Kaidanovich-Beilin O, Fox PL, DiCorleto PE, Wang JA, Qin J, Wald DN, Woodgett JR, Jope RS, Carman J, Dongre A, Li X. Gulen MF, et al. Among authors: sun l. Immunity. 2012 Nov 16;37(5):800-12. doi: 10.1016/j.immuni.2012.08.019. Epub 2012 Nov 8. Immunity. 2012. PMID: 23142783 Free PMC article.

2

Commanding CNS Invasion: GM-CSF.

Zhao J, Sun L, Li X. Zhao J, et al. Among authors: sun l. Immunity. 2017 Feb 21;46(2):165-167. doi: 10.1016/j.immuni.2017.02.003. Immunity. 2017. PMID: 28228272 Free PMC article.

3

Canonical Signaling Pathways in Melanoma.

Sun L, Arbesman J. Sun L, et al. Clin Plast Surg. 2021 Oct;48(4):551-560. doi: 10.1016/j.cps.2021.05.002. Epub 2021 Jul 10. Clin Plast Surg. 2021. PMID: 34503716 Review.

4

A Distinctive Lineage-Negative Cell Population Produces IL-17A in Cutaneous Squamous Cell Carcinoma.

Sun L, Ko J, Vidimos A, Koyfman S, Gastman B. Sun L, et al. J Interferon Cytokine Res. 2020 Aug;40(8):418-424. doi: 10.1089/jir.2020.0039. J Interferon Cytokine Res. 2020. PMID: 32813604

5

Utility of the neutrophil/lymphocyte ratio for predicting malignancy risk and prognosis in patients with dermatomyositis.

Galadari AA, Sun LD, Fernandez AP. Galadari AA, et al. Among authors: sun ld. Clin Exp Dermatol. 2020 Jun;45(4):471-473. doi: 10.1111/ced.14136. Epub 2019 Dec 16. Clin Exp Dermatol. 2020. PMID: 31692021 No abstract available.

6

Analysis of clinical and serologic predictors of response to extracorporeal photopheresis therapy in cutaneous T-cell lymphoma patients.

Sun LD, Polly S, Ko JS, Ricci K, Hsi ED, Cooper KD, Fernandez AP. Sun LD, et al. Photodermatol Photoimmunol Photomed. 2022 Nov;38(6):600-603. doi: 10.1111/phpp.12780. Epub 2022 Feb 21. Photodermatol Photoimmunol Photomed. 2022. PMID: 35132696 No abstract available.

7

Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.

Sun L, Funchain P, Song JM, Rayman P, Tannenbaum C, Ko J, Mcnamara M, Marcela Diaz-Montero C, Gastman B. Sun L, et al. J Immunother Cancer. 2018 May 16;6(1):36. doi: 10.1186/s40425-018-0337-7. J Immunother Cancer. 2018. PMID: 29764498 Free PMC article.

8

Characterization and treatment of prominent facial vasculature in the setting of frontal fibrosing alopecia.

Sun L, Mehrabi S, Khetarpal S, Piliang M. Sun L, et al. J Am Acad Dermatol. 2023 Jan;88(1):174-176. doi: 10.1016/j.jaad.2021.12.051. Epub 2022 Jan 6. J Am Acad Dermatol. 2023. PMID: 34998963 No abstract available.

9

Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors.

Sun L, Arbesman J, Piliang M. Sun L, et al. Arch Dermatol Res. 2021 Jan;313(1):1-10. doi: 10.1007/s00403-020-02094-x. Epub 2020 Jun 9. Arch Dermatol Res. 2021. PMID: 32519001 Review.

10

Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.

Sun L, Chin RI, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT, Koyfman SA, Manyam BV. Sun L, et al. JAMA Dermatol. 2019 Apr 1;155(4):442-447. doi: 10.1001/jamadermatol.2018.5453. JAMA Dermatol. 2019. PMID: 30810715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,928 results

Search Page

Filters